Cogentix Medical Inc (CGNT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cogentix Medical Inc (CGNT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6488
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc is a medical device company that offers patient care products. The company offers products such as macroplastique, PrimeSight, urgent pc and ptq products, among others. Its products are used in critical care, faecal incontinence, urology, bariatric medicine, infection prevention, otolaryngology, gastroenterology, gynecology, and pulmonology specialties, among others. Cogentix Medical also provides bulking agent patient’s application additional process services. The company’s products provide treatment of stress urinary incontinences, faecal incontinence, vesicoureteral reflux, overactive bladder, stress urinary incontinence and overactive bladders, among others. It sells its products through a network of distributors in the US. Cogentix Medical is headquartered in Minnetonka, Minnesota, the US.

Cogentix Medical Inc (CGNT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cogentix Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cogentix Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cogentix Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cogentix Medical Inc, Medical Equipment, Deal Details 10
Partnerships 10
Promepla Enters into Licensing Agreement with Cogentix Medical 10
Merger 11
Uroplasty and Vision-Sciences Merge 11
Equity Offering 12
Vensica Medical Raises USD2 Million in Private Placement 12
Cogentix Medical to Raise USD25 Million in Share Purchase Plan 13
Vision-Sciences Announces Private Placement Of Shares For Up To US$21 Million 14
Acquisition 15
Laborie Medical Acquires Cogentix Medical for USD239 Million 15
Cogentix Medical Acquires Genesis Medical 17
Cogentix Medical Inc – Key Competitors 18
Cogentix Medical Inc – Key Employees 19
Cogentix Medical Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Nov 07, 2017: Cogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company History 22
Aug 01, 2017: Cogentix Medical Reports Strong Second Quarter 24
May 02, 2017: Cogentix Medical Reports First Quarter Operating Results; Urology Revenue Up 11 Percent 25
Mar 09, 2017: Cogentix Medical Reports Strong Fourth Quarter Operating Results 26
Corporate Communications 28
Apr 20, 2017: Ash Keswani Joins Cogentix Medical as SVP of Marketing and Business Development 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Cogentix Medical Inc, Medical Equipment, Key Facts, 2017 2
Cogentix Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cogentix Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cogentix Medical Inc, Deals By Market, 2012 to YTD 2018 8
Cogentix Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Promepla Enters into Licensing Agreement with Cogentix Medical 10
Uroplasty and Vision-Sciences Merge 11
Vensica Medical Raises USD2 Million in Private Placement 12
Cogentix Medical to Raise USD25 Million in Share Purchase Plan 13
Vision-Sciences Announces Private Placement Of Shares For Up To US$21 Million 14
Laborie Medical Acquires Cogentix Medical for USD239 Million 15
Cogentix Medical Acquires Genesis Medical 17
Cogentix Medical Inc, Key Competitors 18
Cogentix Medical Inc, Key Employees 19
Cogentix Medical Inc, Other Locations 20
Cogentix Medical Inc, Subsidiaries 20

List of Figures
Cogentix Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cogentix Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cogentix Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cogentix Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cogentix Medical Inc (CGNT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Northstar Aerospace Inc.:企業の戦略・SWOT・財務情報
    Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report Summary Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The British United Provident Association Ltd:企業の戦略的SWOT分析
    The British United Provident Association Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccibody AS (Vaccibody) is a vaccine company that provides discovery and development of novel immunotherapies, prophylactic and therapeutic vaccines. The company develops VB10.16, a DNA based immunotherapy targeting malignancies caused by human papilloma virus. It conducts exploratory safet …
  • Odebrecht SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Odebrecht S.A. (Odebrecht) is a diversified company. It carries out engineering and infrastructure construction services, development and operation of energy and infrastructure projects and real estate development services. The company executed various engineering and construction projects s …
  • AutoNation, Inc. (AN):企業の財務・戦略的SWOT分析
    AutoNation, Inc. (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Gezhouba Group Co Ltd (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Co Ltd (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • STMicroelectronics NV (STM):医療機器:M&Aディール及び事業提携情報
    Summary STMicroelectronics NV (STM) is a semiconductor company. It develops, manufactures, and markets a wide range of products, including discrete and standard commodity components, full custom devices and semi-custom devices and application-specific standard products, and application-specific inte …
  • Takeda Pharmaceutical Co Ltd (4502):企業の財務・戦略的SWOT分析
    Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beckman Coulter Inc (Beckman), is a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company offe …
  • Tel-Instrument Electronics Corp.:企業の戦略・SWOT・財務情報
    Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report Summary Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bend Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocess …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …
  • Crown Resorts Ltd:企業の戦略・SWOT・財務分析
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Five Prime Therapeutics Inc (FPRX):医療機器:M&Aディール及び事業提携情報
    Summary Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic protei …
  • NETGEAR Inc (NTGR):企業の財務・戦略的SWOT分析
    NETGEAR Inc (NTGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Solaria Energia y Medio Ambiente S.A. (SLR)-エネルギー分野:企業M&A・提携分析
    Summary Solaria Energia y Medio Ambiente, S.A. (Solaria) is a manufacturer and supplier of photovoltaic (PV) modules and cells, and provider of turnkey projects. It designs, manufactures, supplies, and installs PV and thermal solutions for power generation. Its product portfolio includes PV modules …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆